Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience
Philips CT Ambient Experience Philips Ambient Experience for CT with Adult Philips Ambient Experience for MR with Adult Philips Ambient...
Year: 2021
EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US
Initiatives focused on making HIFU procedures broadly accessible to both Medicare and commercially insured patients LYON, France, March 3,...
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
ZUG, Switzerland and CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Market Report Bodes Well for Reflect Scientific Growth Potential
OREM, Utah, March 03, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF). A recent study by Global Market Insights...
Neuronetics Names Cory Anderson Vice President, Clinical Affairs and Medical Operations
Company focuses on driving clinical development for NeuroStar® Advanced Therapy System for mental healthMALVERN, Pa., March 03, 2021 (GLOBE NEWSWIRE)...
RAPT Therapeutics to Participate in Two Investor Conferences in March
SOUTH SAN FRANCISCO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company...
Clubhouse Media Announces Fully Executed LOI to Acquire Top Global Meme Account, Picking Up 7-figure Net Income and a Billion Monthly Impressions
LOS ANGELES, March 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Clubhouse Media Group, Inc. (OTCMKTS:CMGR) (“Clubhouse Media” or the “Company”), an...
Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81%
Data from 25,800 participants in Phase 3 trial in India, received vaccine or placebo in a 1:1 ratio showed that...
Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonists Show Significant Reduction in Binge Eating
-- Model is predictive for human efficacy for binge eating -- -- BMB compound reduced binge eating in rats with...
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections
RAMSEY, N.J. and BOCA RATON, Fla. and KENNESAW, Ga., March 03, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA)...
TCR² Therapeutics to Participate in Two Upcoming Conferences in March
CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company with a pipeline...
Cidara Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
New Published Evidence of Apabetalone’s Beneficial Effects on COVID-19
Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm modelCALGARY, Alberta, March 03, 2021 (GLOBE NEWSWIRE)...
BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing
VANCOUVER, March 03, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:...
MiMedx to Participate at Upcoming Investor Conferences
MARIETTA, Ga., March 03, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MiMedx” or the “Company”), an industry leader...
89bio to Participate in the H.C. Wainwright Global Life Sciences Conference
SAN FRANCISCO, March 03, 2021 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
Topline data from two ongoing COVID-19 studies with KB109 expected in Q1 2021 KB295 study in patients with ulcerative colitis...
Arbor Biotechnologies Names Mark D. Angelino to its Board of Directors
CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies announced today the appointment of Mark D. Angelino, co-founder and...
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
WEST CHESTER, Pa., March 03, 2021 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing...
G1 Therapeutics to Participate in Two Investor Conferences in March
RESEARCH TRIANGLE PARK, N.C., March 03, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...